Daily follicle-stimulating hormone, luteinizing hormone, estradiol, and progesterone in ten women harboring uterine leiomyomas.
Serum follicle-stimulating hormone, luteinizing hormone, estradiol (E2), and progesterone (P) were assessed every day in ten women harboring uterine leiomyomas during a complete menstrual cycle. Total area under the curve was individually calculated for E2 and P. The results obtained in this group were then compared with those obtained in a control population. No statistical difference was found. We concluded that patients harboring uterine leiomyomas had, in this study, a normal menstrual cycle. The role of estrogens in the physiopathology of uterine leiomyoma was not related to abnormally high levels of serum E2 or abnormally low levels of P.
D000328:Adult; D004958:Estradiol / Q000097:blood*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood*; D006801:Humans; D007889:Leiomyoma / Q000097:blood* / Q000503:physiopathology; D007986:Luteinizing Hormone / Q000097:blood*; D011374:Progesterone / Q000097:blood*; D014594:Uterine Neoplasms / Q000097:blood* / Q000503:physiopathology
D011374:Progesterone; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone